| Date | Name | Title | Filing | Type | Shares Traded | Price Range | Total Held |
|---|---|---|---|---|---|---|---|
| Jul 27, 2017 | SVP/GM, Vascular Access | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 282 | $16.36 | 15,324 | |
| Jul 27, 2017 | Director, President and CEO | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 1,958 | $16.36 | 111,817 | |
| Jul 26, 2017 | Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 7,976 | -- | 7,976 | |
| Jul 26, 2017 | SVP/GM, Vascular Access | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 3,342 | -- | 15,606 | |
| Jul 26, 2017 | SVP/GM, Vascular Access | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 11,744 | -- | 11,744 | |
| Jul 26, 2017 | SVP/GM, Vascular Access | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 6,684 | -- | 6,684 | |
| Jul 26, 2017 | Director, President and CEO | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 22,092 | -- | 113,775 | |
| Jul 26, 2017 | Director, President and CEO | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 77,627 | -- | 77,627 | |
| Jul 26, 2017 | Director, President and CEO | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 44,184 | -- | 44,184 | |
| Jul 26, 2017 | Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 7,976 | -- | 55,576 |
For recent transactions, including derivative transactions, see our Section 16 SEC filings page.